Engineers Gate Manager
BLTE icon

Engineers Gate Manager’s Belite Bio BLTE Stock Holding History

Engineers Gate Manager’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Buy
2,773
+284
+11% +$43.5K 0.01% 1601
2026
Q1 		$397K Buy
+2,489
New +$419K 0.01% 1537

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Engineers Gate Manager's BLTE Position: Q2 2026 in Review

Engineers Gate Manager increased its Belite Bio (BLTE) stake by 11% in Q2 2026, buying an estimated $43.5K and bringing the position to 2,773 shares worth $427K. The position accounts for 0.01% of the portfolio, ranked #1601.

Engineers Gate Manager first reported a position in BLTE in Q1 2026 and has held it in 2 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Engineers Gate Manager held 2,773 shares of Belite Bio worth $427K as of Q2 2026.
  • Engineers Gate Manager bought 284 Belite Bio shares in Q2 2026, an estimated $43.5K.
  • Belite Bio made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1601 holding.
  • Engineers Gate Manager first reported a position in Belite Bio in Q1 2026 and has held it in 2 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.